Possible mechanism underlying the potent vasoconstrictor actions of cyclopiazonic acid on dog cerebral arteries

By Asano M.   Kuwako M.   Nomura Y.   Suzuki Y.   Shibuya M.  

European Journal of Pharmacology, Vol. 352, Iss. 2, 1998-07 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

Novel mechanism by which hemoglobin induces constriction of cerebral arteries

By Vollrath B.   Cook D.   Megyesi J.   Findlay J.M.   Ohkuma H.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 311-319

Elsevier

Access to resources Recommend Favorite

Vasoconstrictor responsiveness of tail arteries from endotoxaemic rats

By Ralevic V.   Farmer M.R.   Gardiner S.M.  

European Journal of Pharmacology, Vol. 460, Iss. 2, 2003-01 ,pp. : 145-153

Elsevier

Access to resources Recommend Favorite

Modifications by sumatriptan and acetylcholine of nitric oxide-mediated neurogenic dilatation in dog cerebral arteries

By Ayajiki K.   Fujioka H.   Noda K.   Okamura T.   Toda N.  

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

S1P 3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate

By Salomone S.   Yoshimura S.-i.   Reuter U.   Foley M.   Thomas S.S.   Moskowitz M.A.   Waeber C.  

European Journal of Pharmacology, Vol. 469, Iss. 1, 2003-05 ,pp. : 125-134

Elsevier

Access to resources Recommend Favorite